The emerging role of FTY720 (Fingolimod) in cancer treatment

FTY720 (Fingolimod) is a clinically approved immunomodulating therapy for multiple sclerosis that sequesters T-cells to lymph nodes through functional antagonism of sphingosine-1-phosphate 1 receptor. FTY720 also demonstrates a proven efficacy in multiple in vitro and in vivo cancer models, suggesti...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Christopher, Alshaker, Heba, Cooper, Colin, Winkler, Matthias, Pchejetski, Dmitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029614/
https://www.ncbi.nlm.nih.gov/pubmed/27036015
http://dx.doi.org/10.18632/oncotarget.7145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029614/
https://www.ncbi.nlm.nih.gov/pubmed/27036015
http://dx.doi.org/10.18632/oncotarget.7145

Ejemplares similares